{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:06:02Z","timestamp":1784887562380,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","respiratorycasereports.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.rmcr.2017.07.011","type":"journal-article","created":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T07:01:16Z","timestamp":1501311676000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Synthetic cannabinoid induced acute respiratory depression: Case series and literature review"],"prefix":"10.1016","volume":"22","author":[{"given":"Mark Henry","family":"Alon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Olibrice","family":"Saint-Fleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2017.07.011_bib1","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.86.16_supplement.P2.258","article-title":"Neurologic presentation of K2: a city hospital experience","volume":"86","author":"Kleiman","year":"2016","journal-title":"Neuro"},{"key":"10.1016\/j.rmcr.2017.07.011_bib2","first-page":"618","article-title":"Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use \u2013 United States, January-May 2015","volume":"64","author":"Law","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.rmcr.2017.07.011_bib3","unstructured":"New York City Department of Health and Mental Hygiene. K2- Synthetic Cannabinoids [Internet]. New York. Available from http:\/\/www1.nyc.gov\/site\/doh\/health\/health-topics\/k2.page. [Accessed 19 July 2017]."},{"key":"10.1016\/j.rmcr.2017.07.011_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/cap.2011.0122","article-title":"Synthetic cannabis and respiratory depression","volume":"22","author":"Felicia","year":"2012","journal-title":"J\u00a0Child Adol Psychopharm"},{"key":"10.1016\/j.rmcr.2017.07.011_bib5","series-title":"The Story of Spice","author":"Jack","year":"2009"},{"key":"10.1016\/j.rmcr.2017.07.011_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/cpt.114","article-title":"Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018","volume":"97","author":"Su","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.rmcr.2017.07.011_bib7","unstructured":"NMS. Synthetic Cannabinoids Screen (2016 Scope), Blood Test (9560B) [Internet]. Pennsylvania. Available from http:\/\/www.nmslabs.com\/tests\/Synthetic-Cannabinoids-Screen\u2013Blood\u2013Forensic-\/9560B. [Accessed 22 July 2017]."},{"key":"10.1016\/j.rmcr.2017.07.011_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.drugalcdep.2011.07.011","article-title":"A\u00a0survey study to characterize use of Spice products (synthetic cannabinoids)","volume":"120","author":"Vandrey","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.rmcr.2017.07.011_bib9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1177\/0269881115574493","article-title":"Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample","volume":"29","author":"Winstock","year":"2015","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.rmcr.2017.07.011_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/15563650.2011.584316","article-title":"Three cases of \u2018spice\u2019 exposure","volume":"49","author":"Simmons","year":"2011","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.rmcr.2017.07.011_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.annemergmed.2010.08.039","article-title":"Intoxication from smoking \u2018spice\u2019","volume":"57","author":"Simmons","year":"2011","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.rmcr.2017.07.011_bib12","unstructured":"New York State. Governor Cuomo Issue\u2019s health alert: Illegal Synthetic Marijuana sends more than 160 New Yorkers to the hospital since April 8 [Internet]. Albany, NY. Available from https:\/\/www.governor.ny.gov\/news\/governor-cuomo-issues-health-alert-illegal-synthetic-marijuana-sends-more-160-new-yorkers. [Accessed 19 July 2017]."},{"key":"10.1016\/j.rmcr.2017.07.011_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Uhl GR: discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.rmcr.2017.07.011_bib14","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.rmcr.2017.07.011_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","article-title":"The effects of cannabinoids on the brain","volume":"58","author":"Ameri","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.rmcr.2017.07.011_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/542490","article-title":"The wide and unpredictable scope of synthetic cannabinoids toxicity","author":"Orsini","year":"2015","journal-title":"Case Rep. Crit. Care Epub"},{"key":"10.1016\/j.rmcr.2017.07.011_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.2009.00582.x","article-title":"JWH018, a common constituent of \u2018spice\u2019 herbal blends, is a potent and efficacious cannabinoid CB1 receptor agonist","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.rmcr.2017.07.011_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1749-6632.2011.06199.x","article-title":"Designer drugs: a medicinal chemistry perspective","volume":"1248","author":"Carroll","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.rmcr.2017.07.011_bib19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/dta.268","article-title":"The emergence and analysis of synthetic cannabinoids","volume":"3","author":"Hudson","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.rmcr.2017.07.011_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0960-894X(01)80155-4","article-title":"Design, synthesis and pharmacology of cannabimimetic indoles","volume":"4","author":"Uchiyama","year":"1994","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.rmcr.2017.07.011_bib21","doi-asserted-by":"crossref","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","article-title":"Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in\u00a0vitro and in\u00a0vivo cannabinoid 1 receptor affinity and activity","volume":"6","author":"Brents","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.rmcr.2017.07.011_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","article-title":"Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Delta (9)-THC: mechanism underlying greater toxicity?","volume":"97","author":"Fantegrossi","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.rmcr.2017.07.011_bib23","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/0929867054020864","article-title":"Recent developments in the medicinal chemistry of cannabinomimetic indoles, pyrroles and indenes","volume":"12","author":"Huffman","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.rmcr.2017.07.011_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2013.12.212","article-title":"Synthetic cannabinoids: analysis and metabolites","volume":"97","author":"ElSohly","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.rmcr.2017.07.011_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00210-003-0787-3","article-title":"Analysis of the respiratory effects of cannabinoids in rats","volume":"368","author":"Schmid","year":"2003","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.rmcr.2017.07.011_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.rmcr.2017.07.011_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/anatox\/35.7.487","article-title":"Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites","volume":"35","author":"ElSohly","year":"2011","journal-title":"J.\u00a0Anal. Toxicol."},{"key":"10.1016\/j.rmcr.2017.07.011_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/anatox\/35.7.424","article-title":"Synthetic cannabinoids in oral fluid","volume":"35","author":"Coulter","year":"2011","journal-title":"J.\u00a0Anal. Toxicol."},{"key":"10.1016\/j.rmcr.2017.07.011_bib29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/978-1-61779-465-0_35","article-title":"Homology modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic use","volume":"819","author":"Chang","year":"2012","journal-title":"Methods Mol. Biol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007116302064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007116302064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T21:23:08Z","timestamp":1719350588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007116302064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":29,"alternative-id":["S2213007116302064"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2017.07.011","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic cannabinoid induced acute respiratory depression: Case series and literature review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2017.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}